Revenue Increased 17% Quarter over Quarter Operating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., Nov. 14, 2024 (GLOBE NEWSWIRE) -- . (“Vivos” or the ...
such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos ...
Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...
An unhealthy diet and an indolent life are well known causes of heart disease and stroke. But sleep apnea—where people ...
LivaNova met the primary endpoints for its OSPREY trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation.
LivaNova (LIVN) “announced that it met the primary endpoints for its OSPREY randomized controlled trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation. Together with ...
A Veteran from the Brazos Valley faced the darkest parts of his mind after serving in the US military. He says a device for ...
The global sleep study market is poised for remarkable expansion, with projections indicating a surge in value from USD 6,754 ...
Climate change is increasingly disrupting people’s sleep. High nighttime temperatures led to 5% more hours of sleep lost worldwide over the past five years compared to the period between 1986 ...
TALLAHASSEE, Fla., Oct. 29, 2024 /PRNewswire/ -- Dylan Petkus, MD, leading sleep apnea expert and founder of Optimal Circadian Health, is releasing a new book that's set to shake up the sleep ...
"This may be indicative of an underlying disorder, such as obstructive sleep apnea, and intervention may improve both quality of life and overall health." The study was funded by the National ...
The role of epigenetics — heritable phenotypic changes that don’t alter DNA sequencing — is emerging as a potential marker and target in the diagnosis and management of obstructive sleep apnea. In ...